US$ 29.83
allergic to glp 1 Delayed type hypersensitivity injection site reaction and tolerance induction liraglutide for the treatment of obesity The first successful desensitization protocol
Description
While gastrointestinal side effects remained the most common adverse events, including nausea, vomiting, and diarrhea, the overall safety profile was broadly similar to existing incretin-based therapies

Send your consumer issue to [email protected]

Akram U, Rehman OU, Fatima E, et al
1 Introduction Obesity is a progressing and chronic condition defined by Body Mass Index (BMI) over 30 Kg/m2 levels
GLP-1 drugs maintain an average annual list price of $12,000, with monthly costs between $936 and $1,349 before discounts